martes, 10 de diciembre de 2024

Casgevy costs $2.2 million: First patient outside of a trial receives CRISPR cancer treatment Emily Mullin | Wired | December 9, 2024

https://geneticliteracyproject.org/2024/12/09/casgevy-costs-2-2-million-first-patient-outside-of-a-trial-receives-first-crispr-cancer-treatment/?mc_cid=91601c3b4e&mc_eid=b73600b7ac

No hay comentarios:

Publicar un comentario